Table of content for "Visit esketamine, > 56m" (HCPCS G2083)
General information on the “G2083” code
HCPCS Code: G2083
Long Description: Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation
Short Description: Visit esketamine, > 56m
Original information is taken from G2083 page
Pricing indicators
Pricing Indicator Code 1: 13 – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion). Linked To The Physician Fee Schedule.
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): M1B – Office visits - established
Type Of Service 1: 1 – Medical care
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20200101
Code Effective Date: 20200101
Action Code: N – No maintenance for this code